[Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
D000022:Abortion, Spontaneous / Q000150:complications / Q000276:immunology; D004306:Dose-Response Relationship, Immunologic; D004899:Erythroblastosis, Fetal / Q000276:immunology / Q000517:prevention & control*; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D006801:Humans; D007114:Immunization; D007116:Immunization, Passive / Q000379:methods*; D007140:Immunoglobulin Fab Fragments / Q000008:administration & dosage; D007231:Infant, Newborn; D007518:Isoantibodies / Q000008:administration & dosage* / Q000032:analysis; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000209:etiology / Q000276:immunology / Q000517:prevention & control*; D011263:Pregnancy Trimester, Third; D012203:Rh Isoimmunization / Q000209:etiology / Q000276:immunology / Q000517:prevention & control*; D012204:Rh-Hr Blood-Group System / Q000276:immunology*; D018029:Rho(D) Immune Globulin; D012306:Risk; D013997:Time Factors
D007140:Immunoglobulin Fab Fragments; D007518:Isoantibodies; C033242:RH-antibodies; D012204:Rh-Hr Blood-Group System; D018029:Rho(D) Immune Globulin
Sŭvremenni stanovishta za anti-D profilaktika na rezus-aloimunizatsiiata na bremennata i na khemolitichnata bolest na novorodenoto (literaturen obzor).